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Introduction
The topic of psychological aspects of multiple chemical sensitivity syndrome (MCS) raises some political issues, particularly with individuals who have the disorder and resent being treated as if the problem were imaginary. Therefore, before the topic can be addressed scientifically, some justification sensitive to these concerns must be made for undertaking this avenue of investigation. I propose the following. First, conducting research on possible psychological or psychophysiological contributions to MCS does not imply that MCS is entirely or primarily psychological. Scientific investigation is neutral on the topic. If psychological factors play no role or a minimal role in MCS, a program of good research will be able to establish this firmly. If psychological factors do play a part, then understanding them can only help in the prevention and treatment of this debilitating problem.
Second, if psychological factors are found to play an important role in MCS, this does not necessarily imply that the problem is imaginary. The distinction between psychological and somatic disorders has become blurred in recent years. It is well known that psychological factors can exacerbate a variety of somatic diseases, including headache (1) (2) (3) , ischemic heart disease (4), cancer (5, 6 ), Raynaud's disease (7) , rheumatoid arthritis (8) , asthma (9) , irritable bowel syndrome (10) , chronic pain (11) , and even some infectious diseases (12) . The role of psychological factors in exacerbation of these diseases has been firmly established. Some evidence also exists for a possible contributing role in diathesis.
Conversely, some psychological disorders are known to be triggered by physical ailments that produce similar symptoms. For example, panic disorder and other anxiety disorders have a statistical relationship with the presence of such disorders as mitral valve prolapse (13) , hyperthyroidism (14) , irritable bowel syndrome (15, 16) , and asthma (17, 18) . Although no firm evidence exists regarding the direction of causality, several theories have been proposed implicating these physical disorders as causal factors in panic disorder. Also, psychological disorders including anxiety and depression have been linked to particular kinds of brain pathology, such as depressed levels of serotonin and various structural abnormalities (19, 20) . So even some purely psychological disorders have physiological bases. If a chemical exposure adversely affects the central nervous system, some of the resulting symptoms may look like mental disorders.
Third, finding an important role for psychological procedures in treating MCS does not necessarily exclude the possibility that the disorder is organic in origin. This is true even if these psychological procedures are as effective or more effective than various medical interventions. For example, this is the case for muscle contraction (21) and migraine headaches (22, 23) , irritable bowel syndrome (24, 25) , and Raynaud's disease (26) . Psychological components in treatment programs have proven effective for hypertension (27) , cancer (28, 29) , and epilepsy (30) , to name a few. If exposure to chemicals is a psychological stressor among MCS patients (probably in addition to being a physical trigger of symptoms), a stress-related autonomic reaction also may occur, perhaps superimposed on other physical reactions.
This paper reviews some of the psychophysiological research 
Situatonal Response Specificity
Some tasks elicit characteristic physiological responses (31) . For example, tasks eliciting an attitude of active coping tend to produce a particular response characterized by beta sympathetic activation: increased heart rate and systolic blood pressure, bronchodilation, and increased ventilation (36) (37) (38) (39) . Aversive tasks associated with a more passive response (e.g., watching a scary film) tend to elicit responses such as alpha sympathetic activation (peripheral vasoconstriction), increased cardiotropic parasympathetic activity, and bronchoconstriction (40) (41) (42) .
If exposure to chemicals is a psychological stressor among MCS patients (in addition to possibly being a physical trigger of symptoms), a stress-related autonomic reaction also may occur, perhaps superimposed on other physical reactions. If exposure cannot be avoided, we might expect the psychological component of the response to be similar to the passive coping profile: faintness, increased vagal tone, and asthmalike symptoms. On the other hand, if the individual finds the exposure situation aversive and can avoid it, the response may include rapid heartbeat and perhaps palpitations, bronchodilation, and increased ventilation. These all are common symptoms in MCS. According to this theory, however, if the situation is not perceived to be aversive, no observable autonomic response is expected except that directly produced by the chemical (which should be observable in people without MCS and in lower animals).
There is also evidence that exposure to stimuli previously associated with chemical exposure can produce a strong conditioned psychophysiologial response specific to the particular chemical (43) . Siegel has hypothesized that this response is adaptive in that it may prepare the body for dealing with oncoming chemical exposure more effectively (43) . Thus, as observed in everyday situations, the sight and smell of food elicits various changes in the gastrointestinal tract. Aromas, sights, and sounds associated with a particular place immediately elicit thoughts and often feelings and desires. Perfume elicits such powerful emotional responses that major industries have been capitalizing for centuries on pronounced psychophysiologial effects of chemicals in the air. It is possible that through psychological conditioning such exposures might also elicit physiological reactions that could explain at least some of the symptoms of MCS.
Some specific symptoms of disease can even be triggered by suggestion. In the asthma literature a number of studies have provided evidence that psychogenic asthma attacks can occur even when a person simply thinks that exposure to an asthma trigger has occurred. The typical experimental paradigm here involves telling the asthmatic subject that (s)he is being exposed to an asthma trigger (an allergen or a bronchoconstrictor), and then subjecting the person to a convincing exposure of an inert substance (e.g., nebulized saline or just room air); the subject believes that (s)he has been exposed to a nebulized bronchoconstrictor. Among some asthmatics (between 1 in 4 and 1 in 20, depending on the study), a clinically significant bronchoconstriction occurs (34) . Similarly, bronchodilation may occur in some subjects when they believe they are being exposed to a bronchodilator (44 In addition, the aversiveness associated with exposure can be quantified. Based on previous research on pain and on asthma, it would be useful to measure relevant dimensions of the chemical-induced symptoms.
It is known that most physical symptoms have two independent dimensions: intensity and unpleasantness. Of these, the intensity dimension tends to be more closely related to physical intensity of stimulation, whereas unpleasantness is related to the subject's emotional reaction to the stimulation. These two dimensions have been documented in laboratory studies of experimentally induced pain (50) and dyspnea (51). Tursky et al. (50) developed the Pain Perception Profile, a verbal rating scale for psychophysical estimate of pain. We have adapted it for assessment of dyspnea in asthma (51) . If MCS individuals experience greater discomfort than others but similar levels of perception, this provides some evidence that central nervous system centers involving emotional reactivity (e.g., limbic centers) are sensitized in this population or perhaps that endorphin levels, which may mitigate feelings of discomfort, are particularly low in this population. If sensitivity to the magnitude of the stimulation is elevated among MCS patients, it is possible that sensory nerves and reflexes associated with sensation may be more active among MCS patients. Data from our laboratory suggest that psychological factors may have a greater impact on perception of the unpleasantness of a stimulation than in perception of the magnitude or intensity of the stimulus (52) .
Threshold Detection
Another method for quantifying perceptual sensitivity to stimulation is threshold detection. In this procedure the intensity of exposure in gradually increased to the point at which the individual first feels something. This point is the threshold of detection. Threshold detection studies also can determine the threshold for detecting a "just noticeable difference" in exposure. If MCS patients have lower absolute and difference thresholds than other subjects, it is possible that they are more tuned to reacting to this type of stimulation. Differences in sensitivity may reflect either physiological processes (e.g., greater sensory receptor sensitivity) or psychological processes (e.g., greater alertness to chemical stimulation). A single study by Doty et al. (53) found no differences between MCS patients and normal individuals in the threshold for detecting the odor of phenyl ethyl alcohol and methyl ethyl ketone, but throughout the testing session MCS patients were found to have higher nasal resistances, respiration rates, and Beck Depression inventory scores. These data suggest that MCS patients may not be perceptually more sensitive to odors than other subjects, but they generally exhibit greater depression and decreased nasal patency.
Method ofProduction
Instead of responding verbally in threshold detection tasks, individuals can self-administer stimulation and stop the stimulation when they have reached a threshold of detection. This method can be used in conjunction with the magnitude estimation method; i.e., subjects can estimate the magnitude of discomfort. In one study, our laboratory used this method with patients suffering from muscle contraction headaches (54) . A tourniquet was tied around their upper arms and subjects were asked to pump a ball until they began to feel discomfort, then pain, then pain sufficient to make them want to stop pumping. (To prevent subjects from harming themselves they were not permitted to do this task for more than 1.5 min.) We found that headache patients detected discomfort and pain within shorter time periods than other subjects but reported the pain to be more intense than did the other subjects. This suggested that headache pain patients were more sensitive than others to forms of ischemic pain in areas other than the head. 
